Henry Ji - 30 Aug 2021 Form 4 Insider Report for Sorrento Therapeutics, Inc.

Role
President, CEO and Chairman of the Board of Directors, Director
Signature
/s/ Henry Ji, Ph.D.
Issuer symbol
N/A
Transactions as of
30 Aug 2021
Net transactions value
$0
Form type
4
Filing time
30 Aug 2021, 20:16:55 UTC
Next filing
29 Sep 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SRNEQ Stock option (right to buy) Award $0 +2,500,000 $0.000000 2,500,000 30 Aug 2021 Common Stock 2,500,000 $8.86 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/4th of the original number of shares subject to the option shall vest on August 30, 2022, and 1/48th of the original number of shares subject to the option shall vest following each one month period of service after August 30, 2022, subject to the Reporting Person's continued service to the Issuer through each such vesting date.

Remarks:

President, CEO and Chairman of the Board of Directors